ESBATech, an Alcon Biomedical Research Unit LLC
Records under this name other than the patents ESBATech, an Alcon Biomedical Research Unit LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Back to ESBATech, an Alcon Biomedical Research Unit LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,908,945 | Sequence Based Engineering and Optimization of Single Chain Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 8,293,235 | Humanization of Rabbit Antibodies Using a Universal Antibody Framework Formerly held In force · High confidence | In force | High confidence | |
| US 8,673,310 | Stable and Soluble Antibodies Inhibiting TNF Alpha Formerly held In force · High confidence | In force | High confidence | |
| US 8,937,162 | Humanization of Rabbit Antibodies Using a Universal Antibody Framework Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,422,366 | Stable and Soluble Antibodies Inhibiting TNF Alpha Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,556,265 | Solubility Optimization of Immunobinders Formerly held In force · High confidence | In force | High confidence | |
| US 9,593,161 | Humanization of Rabbit Antibodies Using a Universal Antibody Framework Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,803,027 | Method for Decreasing Immunogenicity Formerly held In force · High confidence | In force | High confidence | |
| US 10,087,244 | Humanization of Rabbit Antibodies Using a Universal Antibody Framework Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,100,111 | Stable and Soluble Antibodies Inhibiting TNF Alpha Formerly held In force · Medium confidence | In force | Medium confidence |